Post by Genedata

Genedata Webinar Week brought together perspectives from Boehringer Ingelheim, Ferring Pharmaceuticals, and Eli Lilly on how leading biopharma teams are standardizing developability data to identify liabilities earlier and make more confident decisions. If you missed any of the four sessions — or want to revisit what you heard — the recordings are available now. Topics covered: • How biologics development challenges are driving workflow innovation (Boehringer Ingelheim)  • Biophysical developability assessment in practice (Ferring Pharmaceuticals)  • Digital transformation of mass spectrometry in biologics discovery (Eli Lilly)  • AI-driven assessment for next-generation biotherapeutics (Genedata) Access the recordings: https://lnkd.in/dR8tjpHp